CD79A and influenza: The current study supports the importance of GPI-anchored CCL28 in the influenza VLPs vaccine formulation in inducing effective, long-lasting mucosal immune responses with strong to moderate protective immunity against homologous and heterologous H3N2 influenza viruses, respectively through the induction of IgA levels in the various mucosal compartments.